openPR Logo
Press release

Carfilzomib Market by Top Players – Amgen Inc., Vijayasri Organics Limited, Tecoland Corporation, Cayman Chemical, Hangzhou Longshine Bio-Tech Co. Ltd., Gyma Laboratories of America Inc.

01-21-2019 06:47 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Big Market Research



Carfilzomib Market By Product Type (Type I and Type II); and End-User (Anti-Cancer and Others); - Global Industry Analysis And Forecast To 2025

Industry Outlook
Carfilzomib is abbreviated as CFZ. Carfilzomib ia an anti-cancer drug used for blocking proteasome cellular complexes that break down protein. Carfilzomib is developed by Onyx Pharmaceuticals and sold under the name Kyprolis. Carfilzomib is used for treatment of people suffering from multiple myeloma (cancer associated to bone marrow), who have been already treated with different medications. Carfilzomib is available in power form which is to be mixed with liquid and injected into the veins. Therefore, the Carfilzomib Market is anticipated to expand and has tremendous scope during the forecast period. The global Carfilzomib Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Get Sample Copy of this Report @

Market Segmentation
The global Carfilzomib Market is based on segment, by Product Type the market is segmented into Type I and Type II; and by End-User the market is segmented into Anti-Cancer and Others.

Regional Insights
On a global front, the Carfilzomib Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA).

Competitive Analysis
The leading players in the market are Amgen Inc., Vijayasri Organics Limited, Tecoland Corporation, Cayman Chemical, Hangzhou Longshine Bio-Tech Co. Ltd., Gyma Laboratories of America Inc., Shanghai Chiral Chemicals and Active Peptide. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

Get a discount on this research report @

Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2014-2025)
4.1.2. Canada Market Status and Outlook (2014-2025)
4.1.3. Mexico Market Status and Outlook (2014-2025)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2014-2025)
4.2.2. France Market Status and Outlook (2014-2025)
4.2.3. UK Market Status and Outlook (2014-2025)
4.2.4. Russia Market Status and Outlook (2014-2025)
4.2.5. Italy Market Status and Outlook (2014-2025)
4.2.6. Rest of Europe Market Status and Outlook (2014-2025)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2014-2025)
4.3.2. Japan Market Status and Outlook (2014-2025)
4.3.3. Korea Market Status and Outlook (2014-2025)
4.3.4. India Market Status and Outlook (2014-2025)
4.3.5. Southeast Asia Market Status and Outlook (2014-2025)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2014-2025)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2014-2025)
4.4.2. Argentina Market Status and Outlook (2014-2025)
4.4.3. Columbia Market Status and Outlook (2014-2025)
4.4.4. Rest of South America Market Status and Outlook (2014-2025)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2014-2025)
4.5.2. United Arab Emirates Market Status and Outlook (2014-2025)
4.5.3. Egypt Market Status and Outlook (2014-2025)
4.5.4. Nigeria Market Status and Outlook (2014-2025)
4.5.5. South Africa Market Status and Outlook (2014-2025)
4.5.6. Turkey Market Status and Outlook (2014-2025)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2014-2025)

Inquiry before Buy @

About Us:
Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.

We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
Call answer Direct: +1-971-202-1575
Call answer Toll Free: +1-800-910-6452

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Carfilzomib Market by Top Players – Amgen Inc., Vijayasri Organics Limited, Tecoland Corporation, Cayman Chemical, Hangzhou Longshine Bio-Tech Co. Ltd., Gyma Laboratories of America Inc. here

News-ID: 1518544 • Views: 462

More Releases from Big Market Research

Strategy Consulting Market 2018: Global Industry Top Manufacturers – The Bosto …
Strategy Consulting Market by Type (Business Strategy Consultants, Sales and Marketing Consultants, Operations Consultants, Investment Consultants and Technology Consultants) and Application (Chemical Industry, Pharmaceutical Industry, Financial Sector, Auto Industry and Others) - Global Industry Analysis & Forecast to 2025 Industry Outlook and Trend Analysis People all over the world are looking for financial stability which can be through various ways like starting your own business, investing the money in the right place
What's driving the Contact Center Software market Share? Genesys Telecommunicati …
The global Contact Center Software market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. Download Request For A Sample Copy Of This Report @ The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States,
What's driving the Fashion Retailing market Share H&M, GAP Inc., Fast Retailing, …
The major driving factor of global fashion retailing market are growing global retail e-commerce sector and increasing middle class consumption expenditure. In addition, rising online fashion penetration rate and rising young population are the some other driving factors that drive the market of fashion retailing. Request for a sample copy of this report @ The major restraining factor of global fashion retailing market are high cost of labor, exchange rate volatility
Long Term Care Market Business Status, Industrial Outlook 2018 and 10 Top Player …
Global Long Term Care Market valued approximately USD 810 billion in 2017 is anticipated to grow with a healthy growth rate of more than 6.2% over the forecast period 2018-2025. The Long Term Care Market is continuously growing in the global scenario at significant pace. Long term care (LTC) service contains a variety of services provided by nursing homes, day care centres, home health agencies and from family or friends.

All 5 Releases

More Releases for Carfilzomib

Blood Cancer Drugs market Comprehensive Growth Analysis With Velcade (Bortezomib …
The ‘Blood Cancer Drugs market’ report published by Market Study Report, LLC, enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. The global blood cancer drugs market is anticipated to reach USD 55.6 billion by 2025 according to a
Trends in Carfilzomib Market: Business Analysis 2018-2025 by SWOT analysis, Shar …
InForGrowth has added a new research article on the healthcare industry category. The report titled " Global Carfilzomib Market Research Report 2018" can be used to gain important insight into this market. Report users can add data from this report to their knowledge of the global market in order to lay a solid foundation for successful business and investment choices in this market. The report provides a professional, progressive, and
Carfilzomib Market Analysis by Application in Vaccination and Other Clinical Are …
Global Carfilzomib Market Professional Survey Report 2018 to 2025 presents an in-depth assessment of the Carfilzomib Market including enabling key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Carfilzomib Market investments from 2018 till 2025. This study answers several questions for stakeholders, primarily which market segments they should focus upon
Global 20s Proteasome Market 2018 -Oprozomib, Carfilzomib, VPEA-002, Others
Apex Market Reports, recently published a detailed market research study focused on the “20s Proteasome Market” across the global, regional and country level. The report provides 360° analysis of “20s Proteasome Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of 20s Proteasome on
Carfilzomib Market Analysis 2017-2022 with Industry Chain Structure, Competitive …
Global Carfilzomib Market reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology. In this report, the global Carfilzomib market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Global Carfilzomib Market, provides a basic overview of the industry including definitions, classifications,
Global Carfilzomib Sales Market Shares, Size, Growth, Analysis, Status Outlook R …
The market for pharmaceutical industry sector is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global Carfilzomib Sales Market Report 2017”, which offer details about the current trends as well as scope for the near future. This research study also covers information about the production and market share based on different active regions. Furthermore, an anticipated growth at a